Logo image of NZM2.DE

NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Analyst Ratings

Europe - Frankfurt Stock Exchange - FRA:NZM2 - DK0060336014 - Common Stock

54.58 EUR
+0.42 (+0.78%)
Last: 1/26/2026, 7:00:00 PM
Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to NZM2.DE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 64.77. This target is 18.67% above the current price.
  • NZM2.DE was analyzed by 22 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about NZM2.DE.
  • In the previous month the buy percentage consensus was at a similar level.
  • NZM2.DE was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

NZM2.DE Historical Analyst RatingsNZM2.DE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 54.5851.3964.7464.7778.73 - -5.85% 18.61% 18.67% 44.25%

Related screens

NZM2.DE Current Analyst RatingNZM2.DE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

NOVONESIS (NOVOZYMES) B / NZM2.DE FAQ

What is the price target for NZM2 stock?

22 analysts have analysed NZM2.DE and the average price target is 64.77 EUR. This implies a price increase of 18.67% is expected in the next year compared to the current price of 54.58.


Can you provide the consensus rating for NOVONESIS (NOVOZYMES) B stock?

The consensus rating for NOVONESIS (NOVOZYMES) B (NZM2.DE) is 73.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed NOVONESIS (NOVOZYMES) B (NZM2.DE)?

The number of analysts covering NOVONESIS (NOVOZYMES) B (NZM2.DE) is 22.